OncoCyte Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 10, 2023 at 12:06 pm
OncoCyte Corporation reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 0.463 million compared to USD 0.237 million a year ago. Net loss was USD 8.33 million compared to USD 8.3 million a year ago. Basic loss per share was USD 1.07 compared to USD 1.48 a year ago.
For the six months, sales was USD 0.76 million compared to USD 0.617 million a year ago. Net loss was USD 5.3 million compared to USD 18.59 million a year ago. Basic loss per share was USD 0.83 compared to USD 3.63 a year ago.